Citations for
1ADCY5, ANO3, DTPC3, DYT5, FDFM, GCH1
Clinical exome sequencing in early-onset generalized dystonia and large-scale resequencing follow-up.
Zech M, Boesch S, Jochim A, Weber S, Meindl T, Schormair B, Wieland T, Lunetta C, Sansone V, Messner M, Mueller J, Ceballos-Baumann A, Strom TM, Colombo R, Poewe W, Haslinger B, Winkelmann J.
Mov Disord ov Disord. 2016 Sep 26. doi: 10.1002/mds.26808. [Epub ahead of print] 2016
2ADCY5, DYT10, DYT10, DYT8, FDFM, GCH1, PNKD, PRRT2
Paroxysmal movement disorders: An update.
Méneret A, Roze E.
Rev Neurol (Paris) 172(8-9):433-445. doi: 10.1016/j.neurol.2016.07.005. 2016
3ADCY5, HNF1B, PDE4C, PKD2
Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases.
Choi YH, Suzuki A, Hajarnis S, Ma Z, Chapin HC, Caplan MJ, Pontoglio M, Somlo S, Igarashi P.
Proc Natl Acad Sci U S A 108(26):10679-84. Epub 2011 Jun 13. 2011
4ADCY5, GLIS3
Effects of 16 genetic variants on fasting glucose and type 2 diabetes in South Asians: ADCY5 and GLIS3 variants may predispose to type 2 diabetes.
Rees SD, Hydrie MZ, O'Hare JP, Kumar S, Shera AS, Basit A, Barnett AH, Kelly MA.
PLoS One 6(9):e24710. doi: 10.1371/journal.pone.0024710. Epub 2011 Sep 20. 2011
5ADCY5, GIPR, VPS13C
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge.
Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, Vollenweider P, Lyssenko V, Bouatia-Naji N, Dupuis J, Jackson AU, Kao WH, Li M, Glazer NL, Manning AK, Luan J, Stringham HM, Prokopenko I, Johnson T, Grarup N, Boesgaard TW, Lecoeur C, Shrader P, O'Connell J, Ingelsson E, Couper DJ, Rice K, Song K, Andreasen CH, Dina C, Köttgen A, Le Bacquer O, Pattou F, Taneera J, Steinthorsdottir V, Rybin D, Ardlie K, Sampson M, Qi L, van Hoek M, Weedon MN, Aulchenko YS, Voight BF, Grallert H, Balkau B, Bergman RN, Bielinski SJ, Bonnefond A, Bonnycastle LL, Borch-Johnsen K, Böttcher Y, Brunner E, Buchanan TA, Bumpstead SJ, Cavalcanti-Proença C, Charpentier G, Chen YD, Chines PS, Collins FS, Cornelis M, J Crawford G, Delplanque J, Doney A, Egan JM, Erdos MR, Firmann M, Forouhi NG, Fox CS, Goodarzi MO, Graessler J, Hingorani A, Isomaa B, Jørgensen T, Kivimaki M, Kovacs P, Krohn K, Kumari M, Lauritzen T, Lévy-Marchal C, Mayor V, McAteer JB, Meyre D, Mitchell BD, Mohlke KL, Morken MA, Narisu N, Palmer CN, Pakyz R, Pascoe L, Payne F, Pearson D, Rathmann W, Sandbaek A, Sayer AA, Scott LJ, Sharp SJ, Sijbrands E, Singleton A, Siscovick DS, Smith NL, Sparsø T, Swift AJ, Syddall H, Thorleifsson G, Tönjes A, Tuomi T, Tuomilehto J, Valle TT, Waeber G, Walley A, Waterworth DM, Zeggini E, Zhao JH; GIANT consortium; MAGIC investigators, Illig T, Wichmann HE, Wilson JF, van Duijn C, Hu FB, Morris AD, Frayling TM, Hattersley AT, Thorsteinsdottir U, Stefansson K, Nilsson P, Syvänen AC, Shuldiner AR, Walker M, Bornstein SR, Schwarz P, Williams GH, Nathan DM, Kuusisto J, Laakso M, Cooper C, Marmot M, Ferrucci L, Mooser V, Stumvoll M, Loos RJ, Altshuler D, Psaty BM, Rotter JI, Boerwinkle E, Hansen T, Pedersen O, Florez JC, McCarthy MI, Boehnke M, Barroso I, Sladek R, Froguel P, Meigs JB, Groop L, Wareham NJ, Watanabe RM.
Nat Genet 42(2):142-8. Epub 2010 Jan 17.PMID: 20081857 2010
6ADCY5, CDKAL1
Type 2 diabetes risk alleles near ADCY5, CDKAL1 and HHEX-IDE are associated with reduced birthweight.
Andersson EA, Pilgaard K, Pisinger C, Harder MN, Grarup N, Færch K, Poulsen P, Witte DR, Jørgensen T, Vaag A, Hansen T, Pedersen O.
Diabetologia 53(9):1908-16. Epub 2010 May 20.PMID: 20490451 2010
7ADCY5, CCNL1, LEKR1
Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight.
Freathy RM, Mook-Kanamori DO, Sovio U, Prokopenko I, Timpson NJ, Berry DJ, Warrington NM, Widen E, Hottenga JJ, Kaakinen M, Lange LA, Bradfield JP, Kerkhof M, Marsh JA, Mägi R, Chen CM, Lyon HN, Kirin M, Adair LS, Aulchenko YS, Bennett AJ, Borja JB, Bouatia-Naji N, Charoen P, Coin LJ, Cousminer DL, de Geus EJ, Deloukas P, Elliott P, Evans DM, Froguel P; Genetic Investigation of ANthropometric Traits (GIANT) Consortium, Glaser B, Groves CJ, Hartikainen AL, Hassanali N, Hirschhorn JN, Hofman A, Holly JM, Hyppönen E, Kanoni S, Knight BA, Laitinen J, Lindgren CM; Meta-Analyses of Glucose and Insulin-related traits Consortium, McArdle WL, O'Reilly PF, Pennell CE, Postma DS, Pouta A, Ramasamy A, Rayner NW, Ring SM, Rivadeneira F, Shields BM, Strachan DP, Surakka I, Taanila A, Tiesler C, Uitterlinden AG, van Duijn CM; Wellcome Trust Case Control Consortium, Wijga AH, Willemsen G, Zhang H, Zhao J, Wilson JF, Steegers EA, Hattersley AT, Eriksson JG, Peltonen L, Mohlke KL, Grant SF, Hakonarson H, Koppelman GH, Dedoussis GV, Heinrich J, Gillman MW, Palmer LJ, Frayling TM, Boomsma DI, Davey Smith G, Power C, Jaddoe VW, Jarvelin MR; Early Growth Genetics (EGG) Consortium, McCarthy MI.
Nat Genet 42(5):430-5. Epub 2010 Apr 6. 2010
8ADCY5, EFNA5, ERC2, GFPT2, GIPC2, GNA14, HSPA4L, MAGI1, MN1, MSX2, MYO5B, OCLN, RSPO1, SALL1, ZNF382
Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia.
Kuang SQ, Tong WG, Yang H, Lin W, Lee MK, Fang ZH, Wei Y, Jelinek J, Issa JP, Garcia-Manero G.
Leukemia 22(8):1529-38. Epub 2008 Jun 5.PMID: 18528427 2008
9ADCY5, ADCY6
Conditional stimulation of type V and VI adenylyl cyclases by G protein betagamma subunits.
Gao X, Sadana R, Dessauer CW, Patel TB.
J Biol Chem 282(1):294-302. Epub 2006 Nov 16. 2007
10ADCY5, RIC8A
Regulation of type V adenylate cyclase by Ric8a, a guanine nucleotide exchange factor.
Wang SC, Lai HL, Chiu YT, Ou R, Huang CL, Chern Y.
Biochem J 406(3):383-8.PMID: 17593019 2007
11AKAP5, PRKACA, ADCY5, ADCY6
Dynamic regulation of cAMP synthesis through anchored PKA-adenylyl cyclase V/VI complexes.
Bauman AL, Soughayer J, Nguyen BT, Willoughby D, Carnegie GK, Wong W, Hoshi N, Langeberg LK, Cooper DM, Dessauer CW, Scott JD.
Mol Cell 23(6):925-31. 2006
12ADCY1, ADCY5, ADCY8
Role of the calcium modulated cyclases in the development of the retinal projections.
Nicol X, Bennis M, Ishikawa Y, Chan GC, Repérant J, Storm DR, Gaspar P.
Eur J Neurosci 24(12):3401-14.PMID: 17229090 2006
13ADCY5,RGS2
Identification of RGS2 and type V adenylyl cyclase interaction sites.
Salim S, Sinnarajah S, Kehrl JH, Dessauer CW.
J Biol Chem 278(18):15842-9. Epub 2003 Feb 25. 2003
14ADCY1, ADCY2, ADCY3, ADCY4, ADCY5, ADCY6, ADCY7, ADCY8, ADCY9
Characterization of the human adenylyl cyclase gene family: cDNA, gene structure, and tissue distribution of the nine isoforms.
Ludwig MG, Seuwen K.
J Recept Signal Transduct Res 22(1-4):79-110. 2002
15ADCY3, ADCY5, ADCY6
Chromosomal mapping of human adenylyl cyclase genes type III, type V, and type VI.
Haber N, et al.
Hum Genet 94 : 69-73. 1994
16ADCY1, ADCY2, ADCY3, ADCY4, ADCY5, ADCY6
Mammalian adenylyl cyclase family members are randomly located on different chromosomes.
Gaudin C, et al.
Hum Genet 94 : 527-529. 1994
17ADCY1, ADCY2, ADCY5, ADCY6, ADCY8
Molecular diversity in the adenylylcyclase family.
Krupinski J, et al.
J Biol Chem 267 : 24858-24862. 1992